SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-14-184569
Filing Date
2014-05-06
Accepted
2014-05-06 14:39:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d723081d424b3.htm 424B3 30451
2 GRAPHIC g723081snap1.jpg GRAPHIC 5838
  Complete submission text file 0001193125-14-184569.txt   39672
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-191238 | Film No.: 14816552
SIC: 2834 Pharmaceutical Preparations